Inflammatory cytokines, high-sensitivity C-reactive protein, and risk of one-year vascular events, death, and poor functional outcome after stroke and transient ischemic …

S Coveney, S Murphy, O Belton… - … Journal of Stroke, 2022 - journals.sagepub.com
Background Inflammation driven by pro-inflammatory cytokines is a new therapeutic target in
coronary disease. Few data exist on the association of key upstream cytokines and post …
被引用次数：30 相关文章

Inflammatory cytokines, high-sensitivity C-reactive protein, and risk of one-year vascular events, death, and poor functional outcome after stroke and transient ischemic …

S Coveney, S Murphy, O Belton… - … journal of stroke …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Inflammation driven by pro-inflammatory cytokines is a new therapeutic target in
coronary disease. Few data exist on the association of key upstream cytokines and post …

Inflammatory cytokines, high-sensitivity C-reactive protein, and risk of one-year vascular events, death, and poor functional outcome after stroke and transient ischemic …

S Coveney, S Murphy, O Belton, T Cassidy… - … Journal of Stroke …, 2021 - europepmc.org
Background Inflammation driven by pro-inflammatory cytokines is a new therapeutic target in
coronary disease. Few data exist on the association of key upstream cytokines and post …

Inflammatory cytokines, high-sensitivity C-reactive protein, and risk of one-year vascular events, death, and poor functional outcome after stroke and transient ischemic …

S Coveney, S Murphy, O Belton… - … Journal of Stroke, 2022 - search.ebscohost.com
Background: Inflammation driven by pro-inflammatory cytokines is a new therapeutic target
in coronary disease. Few data exist on the association of key upstream cytokines and post …